Use access key #2 to skip to page content.
$4.82 -0.23 (-4.55%)
9/4/2008 4:00 PM

BioSante Pharmaceuticals, Inc. (BPAX)

CAPS Rating:
**

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

View All Commentary (BPAX)

Recs

0

Avatar Derrickmarshall (< 20) Submitted: 6/11/08 12:46 AM : Outperform Start Price: $4.31 BPAX Score: 20.94

Possible buyout target

Report this Post Replies: 0 | Reply

Featured Broker Partners